We are live on
!
Find out more
RGC
Roberts, Glore & Co Portfolio holdings
AUM
$364M
1-Year Est. Return
19.54%
This Fund
S&P 500
This Quarter
Est. Return
+5.5%
1 Year Est. Return
+19.54%
3 Year Est. Return
+59.43%
5 Year Est. Return
+77.93%
10 Year Est. Return
+273.65%
AUM
$145M
AUM Growth
+$1.81M
(+1.3%)
Cap. Flow
-$5.25M
Cap. Flow
% of AUM
-3.61%
Top 10 Holdings %
Top 10 Hldgs %
31.24%
Holding
148
New
4
Increased
16
Reduced
107
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
WIW
Western Asset Inflation-Linked Opportunities & Income Fund
WIW
|
+$619K |
| 2 |
Amazon
AMZN
|
+$539K |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$314K |
| 4 |
CERN
Cerner Corp
CERN
|
+$281K |
| 5 |
International Flavors & Fragrances
IFF
|
+$212K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
STJ
St Jude Medical
STJ
|
+$698K |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$380K |
| 3 |
Johnson & Johnson
JNJ
|
+$318K |
| 4 |
Vanguard Morningstar Small-Cap Value ETF
VBR
|
+$317K |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
+$308K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.88% |
| 2 | Financials | 12.07% |
| 3 | Technology | 12.03% |
| 4 | Industrials | 10.32% |
| 5 | Consumer Staples | 7.22% |
Similar funds
VBFP
EW
RBFC
ACM
DCP
MA
SWA
OAJ
Roberts, Glore & Co's Q1 2017 Portfolio in Review
As of Q1 2017, Roberts, Glore & Co held 148 positions worth $145M, up 1.3% from $143M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Roberts, Glore & Co withdrew a net $5.25M in Q1 2017, closing 6 positions and reducing 107 holdings. Its most notable exit was St Jude Medical, an estimated $698K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Financials and Technology.
Against the trend, Roberts, Glore & Co opened a new position in Amazon worth $574K.
- Roberts, Glore & Co's largest Q1 2017 buy was Amazon: 12,940 shares worth $574K.
- Roberts, Glore & Co added most to Western Asset Inflation-Linked Opportunities & Income Fund in Q1 2017, an estimated $619K increase.
- Roberts, Glore & Co's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $318K.
- Roberts, Glore & Co fully exited St Jude Medical in Q1 2017, selling an estimated $698K.
- Roberts, Glore & Co's ten largest holdings make up 31% of its $145M portfolio in Q1 2017.
- Roberts, Glore & Co opened 4 new positions and closed 6 in Q1 2017.
- Roberts, Glore & Co's portfolio value rose 1.3% quarter-over-quarter to $145M.
Based on Roberts, Glore & Co's 13F filing for Q1 2017, filed 15 May 2017.